BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beck C, Morbach H, Richl P, Stenzel M, Girschick HJ. How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases? Rheumatol Int 2009;29:229-38. [PMID: 18821074 DOI: 10.1007/s00296-008-0710-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Gao C, Zhong H, Kong X, Qiao R, Zhang H, Chen B, Gao Y, Li B. TNAP—a potential cytokine in the cerebral inflammation in spastic cerebral palsy. Front Mol Neurosci 2022;15:926791. [DOI: 10.3389/fnmol.2022.926791] [Reference Citation Analysis]
2 Shen S, Duan J, Hu J, Qi Y, Kang L, Wang K, Chen J, Wu X, Xu B, Gu R. Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction. Eur J Pharmacol 2022;:175126. [PMID: 35779623 DOI: 10.1016/j.ejphar.2022.175126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mannes I, Rothenbuhler A, Merzoug V, Di Rocco F, Linglart A, Adamsbaum C. Imaging patterns in pediatric hypophosphatasia. Pediatr Radiol 2021. [PMID: 34854966 DOI: 10.1007/s00247-021-05232-3] [Reference Citation Analysis]
4 Stücker S, Bollmann M, Garbers C, Bertrand J. The role of calcium crystals and their effect on osteoarthritis pathogenesis. Best Pract Res Clin Rheumatol 2021;:101722. [PMID: 34732285 DOI: 10.1016/j.berh.2021.101722] [Reference Citation Analysis]
5 Sekaran S, Vimalraj S, Thangavelu L. The Physiological and Pathological Role of Tissue Nonspecific Alkaline Phosphatase beyond Mineralization. Biomolecules 2021;11:1564. [PMID: 34827562 DOI: 10.3390/biom11111564] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Koga M, Kinoshita Y, Kato H, Kobayashi H, Shinoda Y, Nangaku M, Makita N, Dahir KM, Ito N. Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia. Osteoporos Int 2021. [PMID: 34494146 DOI: 10.1007/s00198-021-06145-5] [Reference Citation Analysis]
7 Kinoshita Y, Mohamed FF, Amadeu de Oliveira F, Narisawa S, Miyake K, Foster BL, Millán JL. Gene Therapy Using Adeno-Associated Virus Serotype 8 Encoding TNAP-D10 Improves the Skeletal and Dentoalveolar Phenotypes in Alpl-/- Mice. J Bone Miner Res 2021. [PMID: 34076297 DOI: 10.1002/jbmr.4382] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Graser S, Liedtke D, Jakob F. TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism. Int J Mol Sci 2021;22:E919. [PMID: 33477631 DOI: 10.3390/ijms22020919] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Charoenngam N, Cevik MB, Holick MF. Diagnosis and management of pediatric metabolic bone diseases associated with skeletal fragility. Curr Opin Pediatr 2020;32:560-73. [PMID: 32692054 DOI: 10.1097/MOP.0000000000000914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vogt M, Girschick H, Schweitzer T, Benoit C, Holl-Wieden A, Seefried L, Jakob F, Hofmann C. Pediatric hypophosphatasia: lessons learned from a retrospective single-center chart review of 50 children. Orphanet J Rare Dis 2020;15:212. [PMID: 32811521 DOI: 10.1186/s13023-020-01500-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 Bianchi ML, Bishop NJ, Guañabens N, Hofmann C, Jakob F, Roux C, Zillikens MC; Rare Bone Disease Action Group of the European Calcified Tissue Society. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int 2020;31:1445-60. [PMID: 32162014 DOI: 10.1007/s00198-020-05345-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
12 Salles JP. Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy. Clin Biochem Rev 2020;41:13-27. [PMID: 32158059 DOI: 10.33176/AACB-19-00031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
13 Feeney C, Stanford N, Lee S, Barry S. Hypophosphatasia and the importance of the general dental practitioner - a case series and discussion of upcoming treatments. Br Dent J 2018;224:937-43. [PMID: 29999027 DOI: 10.1038/sj.bdj.2018.441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
14 Khan A, Josse R, Kannu P, Villeneuve J, Paul T, Van Uum S, Greenberg C. Hypophosphatasia: Canadian update on diagnosis and management. Osteoporos Int 2019;30:1713-22. [DOI: 10.1007/s00198-019-04921-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
15 Luo E, Liu H, Zhao Q, Shi B, Chen Q. Dental-craniofacial manifestation and treatment of rare diseases. Int J Oral Sci 2019;11:9. [PMID: 30783081 DOI: 10.1038/s41368-018-0041-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
16 Bowden SA, Foster BL. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy. Drug Des Devel Ther 2018;12:3147-61. [PMID: 30288020 DOI: 10.2147/DDDT.S154922] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
17 Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology (Oxford) 2018;57:i4-i11. [PMID: 29272515 DOI: 10.1093/rheumatology/kex453] [Cited by in Crossref: 73] [Cited by in F6Publishing: 91] [Article Influence: 18.3] [Reference Citation Analysis]
18 Rucci N, Teti A. The "love-hate" relationship between osteoclasts and bone matrix. Matrix Biol 2016;52-54:176-90. [PMID: 26921625 DOI: 10.1016/j.matbio.2016.02.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
19 Braunstein NA. Multiple fractures, pain, and severe disability in a patient with adult-onset hypophosphatasia. Bone Rep 2016;4:1-4. [PMID: 28326335 DOI: 10.1016/j.bonr.2015.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
20 Bishop N. Clinical management of hypophosphatasia. Clin Cases Miner Bone Metab 2015;12:170-3. [PMID: 26604944 DOI: 10.11138/ccmbm/2015.12.2.170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
21 Bianchi ML. Hypophosphatasia: an overview of the disease and its treatment. Osteoporos Int 2015;26:2743-57. [PMID: 26245849 DOI: 10.1007/s00198-015-3272-1] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
22 Li J, Csakai A, Jin J, Zhang F, Yin H. Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation. ChemMedChem. 2016;11:154-165. [PMID: 26136385 DOI: 10.1002/cmdc.201500188] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
23 Guañabens N, Mumm S, Möller I, González-Roca E, Peris P, Demertzis JL, Whyte MP. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 2014;29:929-34. [PMID: 24123110 DOI: 10.1002/jbmr.2110] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
24 Mckiernan FE, Berg RL, Fuehrer J. Clinical and Radiographic Findings in Adults With Persistent Hypophosphatasemia: HYPOPHOSPHATASEMIA; CLINICAL AND RADIOGRAPHIC FINDINGS. J Bone Miner Res 2014;29:1651-60. [DOI: 10.1002/jbmr.2178] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
25 Tausche A, Aringer M. Chondrokalzinose durch Kalziumpyrophosphat-Dihydrat-Ablagerung (CPPD): Vom radiologischen Zufallsbefund zur CPPD-Kristallarthritis. Z Rheumatol 2014;73:349-59. [DOI: 10.1007/s00393-014-1364-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Costa-reis P, Sullivan KE. Chronic Recurrent Multifocal Osteomyelitis. J Clin Immunol 2013;33:1043-56. [DOI: 10.1007/s10875-013-9902-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
27 Hofmann C, Girschick HJ, Mentrup B, Graser S, Seefried L, Liese J, Jakob F. Clinical Aspects of Hypophosphatasia: An Update. Clinic Rev Bone Miner Metab 2013;11:60-70. [DOI: 10.1007/s12018-013-9139-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
28 Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin Immunol 2013;147:185-96. [PMID: 23369460 DOI: 10.1016/j.clim.2012.12.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
29 Hofmann SR, Roesen-Wolff A, Hahn G, Hedrich CM. Update: Cytokine Dysregulation in Chronic Nonbacterial Osteomyelitis (CNO). Int J Rheumatol 2012;2012:310206. [PMID: 22685464 DOI: 10.1155/2012/310206] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
30 Sabrautzki S, Rubio-Aliaga I, Hans W, Fuchs H, Rathkolb B, Calzada-Wack J, Cohrs CM, Klaften M, Seedorf H, Eck S, Benet-Pagès A, Favor J, Esposito I, Strom TM, Wolf E, Lorenz-Depiereux B, Hrabě de Angelis M. New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis. Mamm Genome 2012;23:416-30. [PMID: 22527485 DOI: 10.1007/s00335-012-9397-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
31 Horvath GL, Schrum JE, De Nardo CM, Latz E. Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol Rev 2011;243:119-35. [PMID: 21884172 DOI: 10.1111/j.1600-065X.2011.01050.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
32 Rock KL, Lai JJ, Kono H. Innate and adaptive immune responses to cell death. Immunol Rev 2011;243:191-205. [PMID: 21884177 DOI: 10.1111/j.1600-065X.2011.01040.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 139] [Article Influence: 12.9] [Reference Citation Analysis]
33 Iida K, Fukushi J, Fujiwara T, Oda Y, Iwamoto Y. Adult hypophosphatasia with painful periarticular calcification treated with surgical resection. J Bone Miner Metab 2012;30:722-5. [DOI: 10.1007/s00774-011-0338-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
34 Mentrup B, Marschall C, Barvencik F, Amling M, Plendl H, Jakob F, Beck C. Functional characterization of a novel mutation localized in the start codon of the tissue-nonspecific alkaline phosphatase gene. Bone 2011;48:1401-8. [PMID: 21419245 DOI: 10.1016/j.bone.2011.03.676] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
35 Rock KL, Latz E, Ontiveros F, Kono H. The sterile inflammatory response. Annu Rev Immunol 2010;28:321-42. [PMID: 20307211 DOI: 10.1146/annurev-immunol-030409-101311] [Cited by in Crossref: 518] [Cited by in F6Publishing: 515] [Article Influence: 43.2] [Reference Citation Analysis]
36 Beck C, Morbach H, Wirth C, Beer M, Girschick HJ. Whole-body MRI in the childhood form of hypophosphatasia. Rheumatol Int 2011;31:1315-20. [PMID: 20383509 DOI: 10.1007/s00296-010-1493-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
37 Morbach H, Dick A, Beck C, Stenzel M, Müller-hermelink HK, Raab P, Girschick HJ. Association of chronic non-bacterial osteomyelitis with Crohn’s disease but not with CARD15 gene variants. Rheumatol Int 2010;30:617-21. [DOI: 10.1007/s00296-009-1029-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]